CME GROUP INC. (CME) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-03-30

Key Insights

The reporting person, William R. Shepard, acquired a significant amount of CME Group Inc. (CME) common stock through a dividend reinvestment plan, increasing their beneficial ownership.
The transactions appear to be routine and in line with the reporting person's ongoing investment in the company.
There are no major changes or noteworthy events reported in this Form 4 filing.

Want the newest filings?

This analysis covers the filing from 2026-03-30. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-03-19

Jonathan L. Marcus, Sr. MD General Counsel of CME Group Inc., sold 3,291 shares of the company's Class A common stock at an average price of $333.37 per share on March 17, 2026.
The sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 18, 2025, indicating a pre-planned insider transaction.
Following the reported transaction, Marcus now directly owns 7,192 shares of CME Group's Class A common stock.

Filed: 2026-03-17

Lynne Fitzpatrick, the President and CFO of CME Group, has acquired 5,504 shares of the company's common stock through the vesting of performance shares granted in 2022. This indicates management's confidence in the company's long-term performance.
Fitzpatrick has also surrendered 2,515 shares to cover tax withholding obligations related to the vesting of the performance shares and restricted stock. This suggests the executive is not cashing out a significant portion of her holdings.
The reported transactions represent a net increase of 2,989 shares in Fitzpatrick's direct beneficial ownership of CME Group's common stock, which now stands at 23,913 shares.

Filed: 2026-03-17

The reporting person, Timothy Francis McCourt, is the Sr. MD Global Head of Equity & FX at CME Group Inc. (CME), indicating that he holds a senior leadership position within the company.
McCourt acquired 5,504 shares of CME Group's Class A common stock through the vesting of performance shares granted in 2022, suggesting he is being compensated through equity-based awards.
McCourt surrendered 2,810 shares to fulfill tax withholding obligations related to the performance share award and an additional 94 shares to fulfill tax withholding obligations upon the vesting of restricted stock, indicating he is proactively managing his equity position.

Filed: 2026-03-17

Jonathan L. Marcus, the Senior Managing Director and General Counsel of CME Group Inc., acquired 5,270 shares of the company's common stock through a performance share award vesting.
To fulfill tax withholding obligations, Marcus surrendered 2,377 and 261 shares, reducing his direct beneficial ownership to 10,483 shares.
The transaction suggests continued confidence by a key executive in the company's long-term performance, as indicated by the vesting of performance-based equity awards.

Filed: 2026-03-17

Hilda Harris Piell, Sr MD & Chief HR Officer of CME Group, acquired 7,076 shares of CME common stock through a vesting of performance shares granted in 2022. This indicates the company's commitment to incentivizing and retaining key executives.
Piell also disposed of 3,039 shares to fulfill tax withholding obligations related to the performance share award, suggesting she plans to hold a substantial portion of the shares received.
The performance share award was based on CME's total shareholder return relative to the S&P 500 over a three-year period, aligning executive compensation with long-term shareholder value creation.

Filed: 2026-03-17

Suzanne Sprague, the COO and Global Head of Clearing at CME Group, exercised 5,504 performance shares that vested on March 15, 2026, indicating the company's strong performance and her commitment to the organization.
Sprague surrendered 2,515 shares (2,439 to fulfill tax withholding obligations and 76 for restricted stock vesting) suggesting she maintains a significant direct ownership position in CME Group.
The reported transactions suggest continued insider confidence in CME Group's business and prospects, as the COO exercises performance shares and retains a meaningful equity stake in the company.

Filed: 2026-03-17

Terrence A. Duffy, the Chairman and CEO of CME Group Inc., acquired 62,902 shares of Class A common stock through a performance share award vesting, indicating his continued commitment to the company.
Duffy also surrendered 27,866 shares to fulfill tax withholding obligations related to the performance share award, which suggests he is managing his equity position responsibly.
The reported transactions provide insight into the company's executive compensation and equity incentive programs, which may be of interest to investors evaluating CME Group's management and corporate governance practices.

Filed: 2026-03-17

Ken Vroman, the Chief Transformation Officer, acquired 7,076 shares of CME Group Inc. (CME) in a performance share award, indicating the company's confidence in his leadership and ability to drive transformation.
Vroman surrendered 3,135 shares to fulfill tax withholding obligations, suggesting a potential cash flow impact but maintaining a significant direct ownership stake of 18,851 shares.
The vesting of performance shares is tied to the company's total shareholder return relative to the S&P 500 over a three-year period, aligning Vroman's compensation with long-term shareholder value creation.

Filed: 2026-03-17

Julie Winkler, the Senior Managing Director and Chief Commercial Officer, exercised 8,256 performance shares that vested based on the company's total shareholder return relative to the S&P 500 over a 3-year period.
Winkler surrendered 3,658 shares to the company to fulfill tax withholding obligations, indicating a partial divestment of her position.
The transaction suggests Winkler maintains significant direct ownership of 30,110 CME Group shares, aligning her interests with those of shareholders.

Filed: 2026-03-17

Derek Sammann, a senior managing director at CME Group, acquired 8,256 shares of CME Group Class A common stock through a performance share award under the company's Omnibus Stock Plan.
Sammann disposed of 3,627 shares to cover tax withholding obligations related to the performance share award, indicating he retained a significant portion of the shares.
Sammann also holds additional indirect beneficial ownership of 11,028 shares in a trust and 7,022 shares through his spouse, suggesting he has a substantial investment in CME Group.

Filed: 2026-03-17

CME Group's Chief Accounting Officer, Jack J. Tobin, acquired 608 shares of common stock through a performance share award vesting, indicating the company's continued commitment to incentivizing key executives.
Tobin also disposed of 179 shares to fulfill tax withholding obligations, suggesting he remains bullish on the company's long-term prospects.
The vesting of performance shares based on the company's total shareholder return relative to the S&P 500 over a three-year period suggests strong financial and operational performance by CME Group.

Filed: 2026-03-17

The reporting person, Sunil Kiran Cutinho, the Chief Information Officer of CME Group Inc., acquired 8,256 shares of the company's common stock through a vesting of performance shares granted in 2022.
Cutinho also disposed of 3,658 shares to fulfill tax withholding obligations related to the receipt of the performance share award, resulting in a net increase of 4,598 shares in his direct ownership of CME Group stock.
This transaction suggests the reporting person's continued confidence in CME Group's performance and aligns his interests with those of the company's shareholders.

Filed: 2026-03-12

The reporting person, Jack J. Tobin, who is the MD Chief Accounting Officer, has disposed of 105 shares of CME Group Inc. common stock.
This transaction represents a small reduction in Tobin's direct ownership of CME stock, which now stands at 24,980 shares.
The transaction was a routine disposal of shares, likely for personal reasons, and does not indicate any significant change in Tobin's position or outlook on the company.

Filed: 2026-03-12

Ken Vroman, the Chief Transformation Officer of CME Group, sold 5,160 shares of Class A common stock on March 12, 2026 at an average price of $309.
This sale represents a decrease in Vroman's direct ownership of CME Group shares from 20,070 to 14,910 shares.
Insider selling, even by high-level executives, can signal potential concerns about the company's future performance or valuation.

Filed: 2026-03-09

Elizabeth A. Cook, a director of CME Group Inc., sold 1,000 shares of the company's common stock at $320 per share.
This sale represents a small portion of Cook's total beneficial ownership of 17,771 shares, which are held indirectly through a trust.
Insider selling can sometimes signal reduced confidence in the company's outlook, though a single transaction may not be indicative of a broader trend.

Other reports for CME GROUP INC.

Current Report Quarterly Report Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.